全球個人化醫療市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全球個人化醫療市場預計將從2025年的4,417.5億美元成長至2034年的1,2,609億美元，2026年至2034年的複合年成長率（CAGR）為12.36%。基因組學和生物技術的進步使得為每位患者量身定做醫療解決方案成為可能，預計將推動個人化醫療市場的顯著成長。個人化醫療是指根據個人特徵（例如基因組成、生活方式和環境因素）客製化治療方案。慢性病盛行率的不斷上升以及對標靶治療需求的成長正在推動對個人化醫療的投資，進一步加速市場擴張。此外，人們日益重視改善患者預後和降低醫療成本，也促進了個人化治療方法的應用。

技術進步在塑造個人化醫療市場的未來前景方面發揮著至關重要的作用。基因測序、生物資訊學和數據分析領域的創新正在提升識別特定生物標記和開發標靶治療的能力。此外，人工智慧 (AI) 和機器學習的整合使醫療專業人員能夠分析大量數據，並就治療方案做出明智的決策。隨著行業的不斷發展，預計個人化醫療市場將在各種醫療環境中進一步採用技術驅動的解決方案。

此外，對病患參與和教育的日益重視也影響著個人化醫療市場的發展軌跡。隨著患者對自身健康狀況和治療方案的了解不斷深入，他們對能夠滿足個別需求的個人化解決方案的需求也日益成長。這一趨勢推動了醫療服務提供者、製藥公司和科技公司之間的合作，以及教育資源和支援系統的開發，使患者能夠在自身的醫療保健決策中發揮積極作用。隨著市場的不斷發展，技術、病患參與和個人化醫療的整合將是成功的關鍵。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球個人化醫療市場：依產品分類

• 市場分析、洞察與預測
• 個人化醫療診斷（基因檢測、生物標記檢測、伴隨診斷、分子影像）
• 個人化醫療治療（標靶治療、基因治療、單株抗體、細胞和基因治療產品）
• 個人化醫療（個人化治療方案、以病人為中心的照護模式、數位健康解決方案、遠端患者監護）
• 個人化營養與健康（營養基因體學、客製化飲食計畫、個人化營養補充品、生活方式改善計畫）

第5章：全球個人化醫療市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 神經病學
• 輸血安全
• 糖尿病
• 自體免疫疾病
• 循環系統
• 其他用途

第6章：全球個人化醫療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷中心
• 研究和學術機構
• 其他最終用戶

第7章 全球個人化醫療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • QIAGEN
  • Abbott
  • Foundation Medicine
  • Guardant Health
  • Natera
  • Exact Sciences
  • Tempus AI
  • Invitae
  • NeoGenomics
  • Labcorp
  • Quest Diagnostics
  • Novartis
  • Pfizer
  • AstraZeneca
  • Merck
  • Bristol Myers Squibb
  • Johnson & Johnson

The global personalized medicine market size is expected to reach USD 1260.90 Billion in 2034 from USD 441.75 Billion in 2025, growing at a CAGR of 12.36% during 2026-2034.The Personalized Medicine Market is poised for significant growth as advancements in genomics and biotechnology enable tailored healthcare solutions. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetic makeup, lifestyle, and environmental factors. The increasing prevalence of chronic diseases and the growing demand for targeted therapies are driving investments in personalized medicine, further propelling market expansion. Additionally, the emphasis on improving patient outcomes and reducing healthcare costs is contributing to the adoption of personalized approaches in treatment.

Technological advancements are playing a crucial role in shaping the future of the personalized medicine market. Innovations in genomic sequencing, bioinformatics, and data analytics are enhancing the ability to identify specific biomarkers and develop targeted therapies. Furthermore, the integration of artificial intelligence and machine learning is enabling healthcare providers to analyze vast amounts of data and make informed decisions regarding treatment options. As the industry continues to evolve, the personalized medicine market is likely to see increased adoption of technology-driven solutions across various healthcare settings.

Moreover, the growing emphasis on patient engagement and education is influencing the personalized medicine market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for personalized solutions that cater to their specific needs. This trend is driving collaboration between healthcare providers, pharmaceutical companies, and technology firms to develop educational resources and support systems that empower patients to take an active role in their healthcare decisions. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Personalized Medicine Diagnostics (Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging)
• Personalized Medicine Therapeutics (Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products)
• Personalized Medical Care (Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring)
• Personalized Nutrition and Wellness (Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs)

By Application

• Oncology
• Neurology
• Blood Transfusion Safety
• Diabetes
• Autoimmune Diseases
• Cardiology
• Other Applications

By End-use

• Hospitals
• Diagnostic Centers
• Research and Academic Institutes
• Other End-Users

COMPANIES PROFILED

• Roche, Thermo Fisher Scientific, Illumina, QIAGEN, Abbott, Foundation Medicine, Guardant Health, Natera, Exact Sciences, Tempus AI, Invitae, NeoGenomics, Labcorp, Quest Diagnostics, Novartis, Pfizer, AstraZeneca, Merck, Bristol Myers Squibb, Johnson & Johnson

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERSONALIZED MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Personalized Medicine Diagnostics (Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Personalized Medicine Therapeutics (Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Personalized Medical Care (Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Personalized Nutrition and Wellness (Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERSONALIZED MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Blood Transfusion Safety Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERSONALIZED MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERSONALIZED MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERSONALIZED MEDICINE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Roche
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 Illumina
  • 9.2.4 QIAGEN
  • 9.2.5 Abbott
  • 9.2.6 Foundation Medicine
  • 9.2.7 Guardant Health
  • 9.2.8 Natera
  • 9.2.9 Exact Sciences
  • 9.2.10 Tempus AI
  • 9.2.11 Invitae
  • 9.2.12 NeoGenomics
  • 9.2.13 Labcorp
  • 9.2.14 Quest Diagnostics
  • 9.2.15 Novartis
  • 9.2.16 Pfizer
  • 9.2.17 AstraZeneca
  • 9.2.18 Merck
  • 9.2.19 Bristol Myers Squibb
  • 9.2.20 Johnson & Johnson